Stroik, Susanna
Carvajal-Garcia, Juan http://orcid.org/0000-0001-7257-3674
Gupta, Dipika http://orcid.org/0000-0002-6512-5256
Edwards, Alyssa http://orcid.org/0000-0002-1968-7186
Luthman, Adam
Wyatt, David W.
Dannenberg, Rachel L.
Feng, Wanjuan
Kunkel, Thomas A. http://orcid.org/0000-0002-9900-1788
Gupta, Gaorav P. http://orcid.org/0000-0001-9177-552X
Hedglin, Mark http://orcid.org/0000-0003-2599-1691
Wood, Richard http://orcid.org/0000-0002-9495-6892
Doublié, Sylvie
Rothenberg, Eli http://orcid.org/0000-0002-1382-1380
Ramsden, Dale A. http://orcid.org/0000-0003-1575-4748
Article History
Received: 12 September 2022
Accepted: 6 October 2023
First Online: 15 November 2023
Competing interests
: D.A.R. has a materials transfer agreement with Artios Pharma and used an Artios Polθ inhibitor for research purposes in this work with no financial compensation. R.D.W. owns shares in Repare Therapeutics, Inc., which also has a Polθ inhibitor.